Covered recipient · General Payments record
CHARLES H FLETCHER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2025
$3,060.57
- Reported across 83 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $551.51 | 7 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | $199.78 | 2 |
| Janssen Pharmaceuticals, Inc | $167.07 | 1 |
| Novo Nordisk AS | $120.52 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $49.77 | 2 |
| Merck Sharp & Dohme Corporation | $14.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ascendis Pharma Endocrinology Inc | $102.00 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237039164 | CMS |
| Ascendis Pharma Endocrinology Inc | $97.78 | 10/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237050513 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.50 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222956324 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.27 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222956326 | CMS |
| Janssen Pharmaceuticals, Inc | $167.07 | 06/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174492837 | CMS |
| Merck Sharp & Dohme LLC | $14.37 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238364923 | CMS |
| Novo Nordisk Inc | $120.52 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188287027 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.